VTRS vs ZBH — Key Metrics

Metric VTRS (VIATRIS INC) ZBH (ZIMMER BIOMET HOLDINGS INC)
Price20.28103.32
Market Cap23.25 Billion19.55 Billion
P/E (TTM)-38.2626.03
P/B (Quarterly)1.5891.639
P/S (TTM)1.582.28
Net Profit Margin (TTM)-4.19.0
Gross Margin (TTM)35.369.7
ROE (TTM)-4.26.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

VIATRIS INC
vs
 
ZIMMER BIOMET HOLDINGS INC
 
VIATRIS INC
vs
 
ZIMMER BIOMET HOLDINGS INC
Performance Comparison
AI Model Recommendation
VTRS · VIATRIS INC

Greatly Outperform

67
UnderperformOutperform
ZBH · ZIMMER BIOMET HOLDINGS INC

Underperform

-16
UnderperformOutperform
Recommendation Summary

Stock VTRS is projected to greatly outperform the market, stock ZBH is projected to underperform the market. Upfront Recommendation: VTRS.

Financial Metrics
Prices delayed ~15 min
VTRS Metrics ZBH
$20.28 Price $103.32
— Market Capitalization —
1.58 Price to Sales 2.28
10.85 Price to FCF Ratio 15.1
4.47 Price to Gross Profit 3.27
23.17 Price to R&D 45.18
2.26 Price to Current Assets 3.81

VTRS vs ZBH at a glance

Viatris INC (VTRS) and Zimmer Biomet Holdings INC (ZBH) are both in the Healthcare sector. VTRS is the larger, at $23.3 billion in market value against $19.6 billion for ZBH, about 1.2 times the size.

On trailing-twelve-month figures, VTRS trades at 1.6 times trailing sales and ZBH at 2.3; net profit margins are -4.1% and 9.0%.

The Upfront Investment model currently rates VTRS Greatly Outperform and ZBH Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.